GlassScriptPhysician profile
Tonya J Ureda
NPI 1518112887
$1,889.67
in general payments reported to CMS, 2019-2025
11 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $234 · 2022: $469 · 2023: $446 · 2024: $229 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $523.51 | 2022-2025 | |
| Servier Pharmaceuticals LLC | $257.17 | 2023-2025 | |
| Sobi, INC | $239.09 | 2023 | |
| Syndax Pharmaceuticals, INC. | $124.56 | 2025 | Revuforj |
| Incyte Corporation | $118.93 | 2021 | |
| Global Blood Therapeutics, INC. | $116.79 | 2022 | |
| Springworks Therapeutics, INC. | $116.78 | 2025 | Gomekli |
| Seagen INC. | $114.97 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $105.36 | 2022 | |
| Emmaus Medical, INC. | $88.49 | 2023 | Endari |
| Y-Mabs Therapeutics, INC. | $84.02 | 2024 | Danyelza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tonya Ureda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.